# Acrivon Therapeutics, Inc.: Form 4, filed Oct 26, 2026

- Company: [Acrivon Therapeutics, Inc.](/companies/acrv.md) (CIK 1781174)
- Form: 4
- Filed: 2026-10-26
- Accepted by EDGAR: Oct 26, 2026, 16:03 ET
- Period: 2026-10-22
- Accession: 0000905148-26-004554
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1781174/000090514826004554/xslF345X06/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781174/000090514826004554/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781174/000090514826004554/xslF345X06/form4.xml

Filed Oct 26, 2026.
Source: SEC EDGAR, the filing index for accession 0000905148-26-004554. Last ingested by Listed: Nov 6, 2026, 12:11 ET. No prices; not investment advice.